20 articles
New research reveals senescent cells have both harmful and protective roles, pushing anti-aging science toward targeted removal strategies.
Scientists found drugs that kill senescent 'zombie cells' by blocking their key survival protein, shrinking tumors in mice.
When the DNA-repair gene EXO1 is overproduced, it damages DNA instead of fixing it—exposing a hidden vulnerability in multiple cancers.
New compound AP503 activates GPR133 receptor to rebuild bone density in mice, offering hope for millions with osteoporosis.
New AI tool automatically identifies cells with chromosomal defects that may lead to cancer, helping scientists study how cancer begins.
Researchers discovered how to restore tumor-killing power in worn-out immune cells by switching off just two genes.
Researchers found 260,000 cancer-specific RNAs that act as molecular fingerprints and can be detected through simple blood tests.
Researchers identify N4BP2, the enzyme behind chromothripsis - a genetic catastrophe that helps one in four cancers rapidly evolve and resist treatment.
Mouse study reveals the FXR bile acid receptor links gut microbes to arterial plaque in sleep apnea, hinting at new preventive targets.
Updated guidelines recommend cholesterol screening in childhood and tracking genetic factors like lipoprotein(a) for personalized prevention.
A Swiss study of 100,000 cases over 40 years reveals colorectal cancer rising steadily in younger adults, with late diagnoses alarmingly common.
MYC protein doesn't just fuel tumor growth — it also repairs DNA damage from chemotherapy, revealing a key resistance mechanism.
Scientists discover D-cysteine selectively targets cancer cells by disrupting their energy production without harming normal cells.
Disabling the NFIL3 protein prevents CAR T cell exhaustion, boosting tumor-fighting power in animal models of hard-to-treat cancers.
Scientists discover how small cell lung cancer uses inflammation to become more aggressive and resistant to treatment.
New biotech innovations are advancing prostate cancer therapy with promising approaches for better patient outcomes.
Breakthrough blood test combining four biomarkers catches deadly pancreatic cancer early when treatment works best, detecting 87.5% of stage I/II cases.
A protein called HOXD13 drives skin cancer growth and shields tumors from immune cells — disabling it could unlock powerful new treatments.
New research reveals why BET inhibitor cancer drugs work in labs but fail in patients, pointing to better treatment strategies.
Australian biotech company creates targeted treatment that attacks malignant plasma cells while sparing healthy ones in multiple myeloma patients.
